Randomized Placebo-Controlled Trial of Glutamine for Breast Cancer Patients With Peripheral Neuropathy
Status:
Completed
Trial end date:
2014-05-01
Target enrollment:
Participant gender:
Summary
Patients with breast cancer receiving paclitaxel chemotherapy who have mild symptoms of
peripheral neuropathy will receive glutamine or placebo to try and improve symptoms.
Phase:
Phase 3
Details
Lead Sponsor:
Linda Vahdat Weill Medical College of Cornell University